95339 ⎘
Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
Sub-classes:PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#2PRODRUGS OF 2-BROMO-LSD (2-BROMOLYSERGIC ACID DIETHYLAMIDE)
#3METHODS OF TREATING PTSD AND NEUROLOGICAL DISORDERS
#4NITROGENATED AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME
#5Platform drug delivery system utilizing crystal engineering and theanine dissolution
#6Nitrogenated aromatic heterocyclic derivative and organic electroluminescent element using same
#7Process for producing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid and complexes thereof
#8Fluoroergoline analogs
#9Ergoline derivatives as dopamine receptor modulators
#10Fluoroergoline analogs
#11NOVEL SUBSTITUTED INDOLO 4,3 FG QUINOLINES USEFUL FOR TREATING MIGRAINE
#12Nitrogenated aromatic heterocyclic derivative, and organic electroluminescent element using same
#13Fluoroergoline analogs
#14Substituted indolo 4,3 FG quinolines useful for treating migraine
#15PREPARATION OF MICROBIOLOGICALLY PRODUCED ERGOT ALKALOIDS
#16Efficient process for the preparation of cabergoline and its intermediates
#17Process for the manufacture of lysergic acid
#18Process for making cabergoline
#19Methods of using 1-allyl ergot alkaloid derivatives to treat migraines
#20Process for the synthesis of pergolide